Zai Lab (ZLAB) Revenue (2019 - 2026)
Zai Lab (ZLAB) posted Revenue of $99.6 million for Q1 2026, down 21.93% sequentially from $127.6 million in Q4 2025, and down 6.46% YoY from $106.5 million in Q1 2025.
Zai Lab (ZLAB) Revenue (2019 - 2026) Analysis & Trends
Zai Lab has reported Revenue for 8 years, with the latest figure at $99.6 million in Q1 2026.
- Quarterly Revenue fell 6.46% year-over-year to $99.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $453.3 million (up 8.36% YoY) and the FY2025 annual result came in at $460.2 million, up 15.33% from the prior year.
- Revenue fell to $99.6 million in Q1 2026 per ZLAB's latest filing, from $127.6 million in the prior quarter.
- Over five years, Revenue peaked at $127.6 million in Q4 2025 and troughed at $46.7 million in Q1 2022.
- A 5-year average of $84.7 million and a median of $87.1 million in 2024 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2026: Revenue soared 132.42% in 2022, then declined 6.46% in 2026.
- Over 5 years, Revenue stood at $62.6 million in 2022, then climbed by 5.16% to $65.8 million in 2023, then soared by 65.68% to $109.1 million in 2024, then grew by 16.99% to $127.6 million in 2025, then slipped by 21.93% to $99.6 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $99.6 million, $127.6 million, and $116.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 106.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.31 Mn |
| Mar 31, 2026 | 99.61 Mn |
| Dec 31, 2025 | 127.60 Mn |
| Sep 30, 2025 | 116.10 Mn |
| Jun 30, 2025 | 109.98 Mn |
| Mar 31, 2025 | 106.49 Mn |
| Dec 31, 2024 | 109.07 Mn |
| Sep 30, 2024 | 102.27 Mn |
| Jun 30, 2024 | 100.50 Mn |
| Mar 31, 2024 | 87.15 Mn |
| Dec 31, 2023 | 65.83 Mn |
| Sep 30, 2023 | 69.23 Mn |
| Jun 30, 2023 | 68.86 Mn |
| Mar 31, 2023 | 62.80 Mn |
| Dec 31, 2022 | 62.60 Mn |
| Sep 30, 2022 | 57.54 Mn |
| Jun 30, 2022 | 48.18 Mn |
| Mar 31, 2022 | 46.72 Mn |
| Dec 31, 2021 | 43.96 Mn |
| Sep 30, 2021 | 43.10 Mn |